INOVIO PHARMACEUTICALS, INC. Public Float
INOVIO PHARMACEUTICALS, INC. (INO) had Public Float of $74.30 million as of 2025-06-30, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-12
- 2025-06-30: Entity Public Float $74.30M.
- 2024-06-30: Entity Public Float $208.00M.
- 2023-06-30: Entity Public Float $119.70M.
- 2022-06-30: Entity Public Float $425.50M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $74.30M 10-K · filed 2026-03-12 |
| 2024-06-30 | $208.00M 10-K · filed 2025-03-18 |
| 2023-06-30 | $119.70M 10-K · filed 2024-03-06 |
| 2022-06-30 | $425.50M 10-K · filed 2023-03-01 |
| 2021-06-30 | $1.90B 10-K · filed 2022-03-01 |
| 2020-06-30 | $4.20B 10-K · filed 2021-03-01 |
| 2019-06-28 | $279.66M 10-K · filed 2020-03-12 |
| 2018-06-30 | $336.00M 10-K · filed 2019-03-12 |
| 2017-06-30 | $608.65M 10-K · filed 2018-03-14 |
| 2016-06-30 | $632.08M 10-K · filed 2017-03-15 |
| 2015-06-30 | $555.19M 10-K · filed 2016-03-14 |
| 2014-06-30 | $614.64M 10-K · filed 2015-03-16 |
| 2013-06-30 | $133.20M 10-K · filed 2014-03-17 |
| 2012-06-30 | $56.10M 10-K · filed 2013-03-18 |
| 2011-06-30 | $76.35M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |